Carol Suh

Carol Suh is currently a partner at Arch Venture Partners. Before that, they were an associate director of corporate development at Boundless Bio. Prior to that, they worked as a business development and corporate strategy associate at Magenta Therapeutics and as a senior associate consultant at Trinity Partners. Carol also has experience working in R&D strategy and innovation from their time as a fellow at GlaxoSmithKline. Carol has a proven track record in helping companies launch and grow, and they are excited to continue doing so as a partner at Arch Venture Partners.

Carol Suh has a Master of Business Administration from Stanford University Graduate School of Business, a Master of Philosophy in Genetics from Yale University, and a Bachelor of Arts in Molecular and Cellular Biology from Harvard University.

Some of their coworkers include Steve Gillis - Managing Director, Ari Nowacek - Principal, and Paul Berns - Managing Director. Carol Suh reports to Robert Nelsen, Co-Founder & Managing Director.